Allergen (AGN) PT Raised to $220 at RBC Capital

October 24, 2018 6:49 AM EDT Send to a Friend
RBC Capital analyst Randall Stanicky raised the price target on Allergen (NYSE: AGN) to $220.00 (from $213.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login